Sdz 215-811 is a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors. References: Bruns C, Stolz B, Albert R, Marbach P, Pless J. OctreoScan 111 for imaging of a somatostatin receptor-positive islet cell tumor in rat. Horm Metab Res Suppl. 1993;27:5-11. PubMed PMID: 8392488.

纯度：≥98%

CAS：142694-57-3